Hint mode is switched on Switch off

Akebia Therapeutics, ordinary share
US00972D1054, AKBA

Add a stock to WL
Choose all Reset all
Akebia Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

  • Issuer
  • Full borrower / issuer name
    Akebia Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    AKBA
  • Placement
    20.03.2014
  • Lock up period
    180
  • Number of papers
    5,882,353
  • Volume of raised funds
    100 mln USD
  • Final placement price
    17 USD
  • Price change since placement date
    -91.94%
  • By capitalization
    327.56 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    AKBA
  • Placement
    17.04.2015
  • Lock up period
    180
  • Number of papers
    7,272,727
  • Volume of raised funds
    60 mln USD
  • Placement share
    26.21%
  • Final placement price
    8.25 USD
  • Price change since placement date
    -83.39%
  • By capitalization
    228.91 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    AKBA
  • Placement
    29.06.2017
  • Lock up period
    180
  • Number of papers
    4,000,000
  • Volume of raised funds
    58 mln USD
  • Placement share
    8.6%
  • Final placement price
    14.5 USD
  • Price change since placement date
    -90.55%
  • By capitalization
    674.06 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Related Stock indices

Indicators

News

17/04/2024 Akebia Therapeutics: Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant
15/04/2024 Akebia Therapeutics: Entry Into A Material Definitive Agreement
27/03/2024 Akebia Therapeutics: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
08/02/2024 Akebia Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers;
29/01/2024 Akebia Therapeutics: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement, Unregistered Sales Of Equity Securities
All organization news

Holders

Industry Leaders

Registration is required to get access.